Literature DB >> 10941203

New pulsatile bioreactor for in vitro formation of tissue engineered heart valves.

S P Hoerstrup1, R Sodian, J S Sperling, J P Vacanti, J E Mayer.   

Abstract

Two potential obstacles to the creation of implantable tissue engineered heart valves are inadequate mechanical properties (ability to withstand hemodynamic stresses) and adverse host-tissue reactions due to the presence of residual nondegraded polymer scaffold. In an attempt to address these problems, we developed an in vitro cell culture system that provides physiological pressure and flow of nutrient medium to the developing valve constructs. It is anticipated that in vitro physical stress will stimulate the tissue engineered heart valve construct to develop adequate strength prior to a possible implantation. Long-term in vitro development will be realized by an isolated and thereby contamination-resistant system. Longer in vitro development will potentially enable more complete biodegradation of the polymeric scaffold during in vitro cultivation. This new dynamic bioreactor allows for adjustable pulsatile flow and varying levels of pressure. The system is compact and easily fits into a standard cell incubator, representing a highly isolated dynamic cell culture setting with maximum sterility, optimal gas supply and stable temperature conditions especially suited for long-term experiments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10941203     DOI: 10.1089/107632700320919

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  24 in total

Review 1.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

Review 2.  Umbilical cord cells as a source of cardiovascular tissue engineering.

Authors:  Christian Breymann; Dörthe Schmidt; S P Hoerstrup
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 3.  EMT-inducing biomaterials for heart valve engineering: taking cues from developmental biology.

Authors:  M K Sewell-Loftin; Young Wook Chun; Ali Khademhosseini; W David Merryman
Journal:  J Cardiovasc Transl Res       Date:  2011-07-13       Impact factor: 4.132

4.  Development of a novel pulsatile bioreactor for tissue culture.

Authors:  Yos S Morsi; William W Yang; Amal Owida; Cynthia S Wong
Journal:  J Artif Organs       Date:  2007-06-20       Impact factor: 1.731

Review 5.  Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices.

Authors:  Dörthe Schmidt; Ulrich A Stock; Simon P Hoerstrup
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

6.  Development of a tissue engineered heart valve for pediatrics: a case study in bioengineering ethics.

Authors:  W David Merryman
Journal:  Sci Eng Ethics       Date:  2008-02-12       Impact factor: 3.525

7.  A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology.

Authors:  George C Engelmayr; Lorenzo Soletti; Sarah C Vigmostad; Stephanus G Budilarto; William J Federspiel; Krishnan B Chandran; David A Vorp; Michael S Sacks
Journal:  Ann Biomed Eng       Date:  2008-02-06       Impact factor: 3.934

8.  Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue.

Authors:  Zeeshan H Syedain; Justin S Weinberg; Robert T Tranquillo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

9.  A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions.

Authors:  Sharan Ramaswamy; Steven M Boronyak; Trung Le; Andrew Holmes; Fotis Sotiropoulos; Michael S Sacks
Journal:  J Biomech Eng       Date:  2014-12       Impact factor: 2.097

10.  Design and physical characterization of a synchronous multivalve aortic valve culture system.

Authors:  Christopher A Durst; K Jane Grande-Allen
Journal:  Ann Biomed Eng       Date:  2009-12-02       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.